Dr. Matthew G. Vanderheiden, MD, PhD
- Medicare patients, 2024
- 15
- Part D claims, 2018
- 13
- MIPS score, 2024
- 84
- Hospital affiliations
- 2
- Industry payments
- $368,266
- Practice address
- 75 Francis Street, Boston, MA 02115
- Practice phone
- Call (617) 732-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Vanderheiden's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew G. Vanderheiden is a hematologist and oncologist in Boston, Massachusetts
Dr. Vanderheiden practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. Vanderheiden's NPI, 1356312946, was assigned on January 31, 2006. Dr. Vanderheiden graduated from University of Chicago, Pritzker School of Medicine in 2002. Dr. Vanderheiden holds Massachusetts license 222812.
- NPI
- 1356312946NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4385678473
- NPI enumeration date
- January 31, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (617) 732-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew G. Vanderheiden practices at Brigham and Women's Hospital in Boston, Massachusetts
Dr. Vanderheiden's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.
- Brigham and Women's Hospital75 Francis Street, Boston, MA 02115 · Suffolk CountyPhone(617) 732-5500
Source: Dmand AI Affiliation Data
Dr. Matthew G. Vanderheiden is affiliated with 3 sites of care and 1 medical group
Dr. Vanderheiden's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Vanderheiden is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Vanderheiden to 1 more hospital outpatient department, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Matthew G. Vanderheiden's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanderheiden practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Brigham and Women's Hospital | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew G. Vanderheiden is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Vanderheiden's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vanderheiden is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Vanderheiden
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew G. Vanderheiden treated 15 Medicare patients in 2024, average age 75
CMS counts 15 Medicare patients who saw Dr. Vanderheiden in 2024. The largest group is under 65, with 0 patients. 75% of them have cancer. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Vanderheiden's median patient age at 72, with 0% women.
Dr. Vanderheiden's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Vanderheiden's Medicare patients, 2024
- Cancer75%
Share of Medicare patients with each condition. A patient can have several.
Dr. Vanderheiden's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women0%
- Men100%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew G. Vanderheiden wrote 13 Medicare Part D claims in 2018
In 2018, Dr. Vanderheiden wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $143,780 in total drug cost. In 2017, CMS named 19 claims across 1 drug.
Dr. Vanderheiden's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 192018: 1332%
Drugs named by CMS: 1 in 2018, 1 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Matthew G. Vanderheiden scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Vanderheiden for performance year 2024, reported as part of a group. Dr. Vanderheiden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Vanderheiden's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew G. Vanderheiden received $368,266 in industry payments from 2017 to 2025
CMS Open Payments shows 73 general payments to Dr. Vanderheiden from 4 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 100% of the total. Agios Pharmaceuticals, Inc. paid the most, $360,000.
General payments to Dr. Vanderheiden by program year, 2017 to 2025
General payments to Dr. Vanderheiden by kind, 2017 to 2025
- Consulting fees$368,250100%
- Food and beverage$160%
Companies that paid Dr. Vanderheiden the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew G. Vanderheiden graduated from University of Chicago, Pritzker School of Medicine
Dr. Vanderheiden graduated from University of Chicago, Pritzker School of Medicine in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew G. Vanderheiden's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew G. Vanderheiden
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew G. Vanderheiden's NPI number?
Dr. Matthew G. Vanderheiden's NPI number is 1356312946. It was assigned on January 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew G. Vanderheiden?
Dr. Matthew G. Vanderheiden is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Matthew G. Vanderheiden practice?
Dr. Vanderheiden practices at 75 Francis Street, Boston, MA 02115. Dr. Vanderheiden's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Vanderheiden to 1 hospital outpatient department.
What is Dr. Matthew G. Vanderheiden's office phone number?
The practice phone on file for Dr. Vanderheiden is (617) 732-5500.
What is Dr. Matthew G. Vanderheiden's medical license number?
Dr. Vanderheiden holds Massachusetts license 222812.
Which hospitals is Dr. Matthew G. Vanderheiden affiliated with?
Dr. Vanderheiden practices at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Vanderheiden is also affiliated with Dana-Farber Cancer Institute.
What medical group is Dr. Matthew G. Vanderheiden part of?
Dr. Vanderheiden is linked to Binney Medical Group.
Does Dr. Matthew G. Vanderheiden accept Medicare?
Yes. CMS lists Dr. Vanderheiden as accepting Medicare assignment.
What is Dr. Matthew G. Vanderheiden's MIPS score?
Dr. Vanderheiden's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Matthew G. Vanderheiden see?
CMS counts 15 Medicare patients who saw Dr. Vanderheiden in 2024, with an average age of 75.
Show 4 more questionsShow fewer questions
Where did Dr. Matthew G. Vanderheiden go to medical school?
Dr. Vanderheiden graduated from University of Chicago, Pritzker School of Medicine in 2002.
What drugs does Dr. Matthew G. Vanderheiden prescribe most?
In 2018 Medicare Part D data, Dr. Vanderheiden's most prescribed drugs by claims were Xtandi.
Has Dr. Matthew G. Vanderheiden received payments from drug or device companies?
CMS Open Payments shows $368,266 in general payments to Dr. Vanderheiden from 4 companies from 2017 to 2025. The largest total came from Agios Pharmaceuticals, Inc.
How long has Dr. Matthew G. Vanderheiden been practicing?
Dr. Vanderheiden graduated from medical school in 2002, 24 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card